For our Spotlight on biomarker discovery and development we carried out a survey to gain insights into biomarkers used, their challenges and future outlook.
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
Much progress has been made on blood-based biomarkers for neurological diseases, though challenges in this field should be addressed before they are applied into clinical use.
In this review from Biomarkers in Medicine, researchers demonstrate that PARK7 and NDKA could present more clinical important information as biomarkers for management of stroke disease.
Complete our short survey on biomarker discovery and development in neurological disorders and be the first to receive our infographic collated from the survey results.
In this review article from Biomarkers in Medicine, researchers explore the current application of blood-based markers to assess amyloid-β pathology.
In this research article from Biomarkers in Medicine, researchers determine if serum levels of tau and BDNF can be used as severity biomarkers in multiple sclerosis.
Researchers have identified a simple blood test that may be able to diagnose neurodegeneration before symptoms arise; this could lead to earlier diagnosis of Alzheimer’s disease.
We had the pleasure of filming a joint seminar from the Michael J Fox Foundation and Abcam on biomarkers of neuroinflammation in Parkinson’s disease. Discover more about this in our video, with timepoints for each slide included.
In this interview, we had the pleasure of speaking with Robert Fox about biomarker discovery and development in multiple sclerosis, including serum neurofilament light.